Velocity of Ultrasonic Waves in Solutions of Electrolytes

List of the genes involved in CVDs according to DisGeNET database. For each gene all the related diseases and the putative EV-MiRNAs targeting it are indicated both as list and as number of occurrences. (PDF 1206 kb

Blood DNA methylation levels (%mC) in Day 1 and Day 4 samples.

<p>Blood DNA methylation levels (%mC) in Day 1 and Day 4 samples.</p

Sequence characteristics of the DNA methylation markers analyzed.

*<p><i>Alu</i> and LINE-1 were not considered, as repeat elements have multiple locations across the human genome with different context sequence characteristics.</p

Correlations of intraclass correlation coefficients (ICCs) with DNA methylation levels and genomic characteristics of the sequences analyzed.

<p>The panels show correlations of ICCs for each of the methylation biomarkers with content of guanosine and cytosine (G+C, panel A); ratio of observed/expected CpG dinucleotides (CpG o/e; panel B); distance of repeat elements from 3′ (panel C); distance of repeat elements from 5′ (panel D); DNA methylation mean on Day 1 (panel E); range of DNA methylation on Day 1 (panel F). The scatter plots use ICC values subtracted of pyrosequencing measurement errors (ICC₁) and estimated from models adjusted by PM₁₀ exposure levels, age, current smoking, and percent blood granulocytes. Each data point corresponds to the ICC₁ value for one biomarker, as indicated by the corresponding label.</p

Representative scatter plots (Day 1 vs. Day 4 blood DNA methylation measures) of the biomarkers with highest (<i>IL-6</i>, panel A) and lowest (<i>APC</i>, panel B) intra-class correlation coefficients.

<p>Representative scatter plots (Day 1 vs. Day 4 blood DNA methylation measures) of the biomarkers with highest (<i>IL-6</i>, panel A) and lowest (<i>APC</i>, panel B) intra-class correlation coefficients.</p

Additional file 1: Figure S1. of Extracellular vesicle-packaged miRNA release after short-term exposure to particulate matter is associated with increased coagulation

Diagram describing the two-stage, split-sample study design for miRNA analysis. (PDF 307 kb

Baseline prevalence (%) of distressing somatic symptoms in past 7 days by sex and age.

<p>Baseline prevalence (%) of distressing somatic symptoms in past 7 days by sex and age.</p

Specification and recruitment of study sample.

<p>Specification and recruitment of study sample.</p

Access to healthcare for musculoskeletal disorders.

<p>Access to healthcare for musculoskeletal disorders.</p

Adverse health beliefs regarding low back and arm pain – prevalence (%) by occupational group.

a<p>Completely agree that such pain is commonly caused by people’s work.</p>b<p>Completely agree that for someone with such pain, a) physical activity should be avoided as it might cause harm, and b) rest is needed to get better.</p>c<p>Completely agree that for someone with such pain, rest is needed to get better, and completely disagree that such problems usually get better within three months.</p